Topic: Vioxx

Merck fined $950 mn over painkiller marketing

Pharmaceutical giant Merck will pay nearly $1 billion to resolve criminal and civil charges for wrongfully marketing its former hit painkiller Vioxx, the US Department of Justice said.Merck agreed to plead guilty to breaking the Food, Drug, and Cosmetic Act after it ...

Investing in health care stocks

Usually, health care stocks fare a little better than the rest of the market, and are viewed as a safe sector. ROLE OF THE FEDERAL DRUG ADMINISTRATION ("FDA") In recent years, the FDA has been taking more time to approve new drugs, ...
This is certainly a problem and it has resulted in some drugs such as Vioxx to be approved as safe and effective when in fact it significantly raised the risk of myocardial infarction (heart attack) and several thousand people died as a ...
Drugs pulled from the market include the painkiller Vioxx and diet pills Pondimin and ReduxWhen a drug's risks exceed its benefits, the federal Food and Drug Administration may ask or order a company to withdraw it from the market, or a company ...
Mass. doctor accused of faking painkiller studies pleads guilty to federal health care fraud A doctor accused of faking research for a dozen years in published studies that suggested after-surgery benefits from painkillers including Vioxx and Celebrex pleaded guilty Monday to one ...
Taking an older drug instead of a new blockbuster can help you save money and stay safeLast year pharmaceutical companies spent more than $4 billion urging patients like you to " The senior advocacy group AARP reports that prices for the most ...

Merck settles Vioxx lawsuits

The article reports that Merck Co. Inc. will be paying nearly $5 billion in order to settle legal claims to patients that used the drug Vioxx, manufactured by it. It is stated that the controversy surrounding the use of Vioxx has dogged ...
When questions first emerged about a small study testing their $5 billion cholesterol pills Zetia and Vytorin, Merck (nyse: The New England Journal of Medicine even published two editorials telling doctors to use them as a last resort (a conclusion Merck and ...

The End Of Merck

s decision to purchase smaller rival Schering-Plough for $41.1 billion risks losing much of what made Merck so wonderful in the first place.. Though there were downsides to Merck's old culture, including a bad case of not-invented-here syndrome, it also was an ...
Stricter regulation, a dearth of new blockbuster drugs, increased pressure to lower prices and more intense generic competition hammered the pharmaceutical industry in 2008, but its stocks still weathered the market collapse better than many other sectors.The industry's ills predate the financial ...
Previous
  • 1
  • 2